Endoscopic retrograde cholangiopancreatography (ERCP) SpyGlass

Feature Summary

Endoscopic retrograde cholangiopancreatography (ERCP)

ERCP is a technique that combines the use of endoscopy and fluoroscopy to diagnose and treat certain diseases of the biliary or pancreatic ductal systems.



The biliary tract diseases include bile duct stones, cholangitis, tumors, congenital bile duct anomalies or post-operative complications, leading to bile duct stricture and/or obstructive jaundice. Pancreatic cancer, pancreatic tumors, chronic pancreatitis and congenital pancreatic anomalies can result in pancreatic duct stricture, stone formation or chronic pancreatic pain.



ERCP is used to diagnose and treat diseases of the biliary or pancreatic ductal systems. The therapeutic indications include endoscopic sphincterotomy, removal of stones, and insertion of bile duct stents for benign or malignant biliary and pancreatic strictures.



Under sedation, an endoscope is inserted through mouth into the duodenum. Through the scope, a catheter is inserted into the ampulla of Vater and radiocontrast is injected into the bile ducts and/or pancreatic duct. Fluoroscopy is used to look for intra-ductal lesions, such as stones or stricture. Several therapeutic procedures can be performed during ERCP, including endoscopic sphincterotomy, removal of stones or other biliary debris, lithotripsy and insertion of bile duct stents. Cholangioscopy (SpyGlass) can also be performed with ERCP for direct visual diagnosis, biopsy, or laser lithotripsy.



  • GI tract bleeding, incidence rate around 0.8~2%。
  • GI tract perforation, incidence rate around 0.3~0.6%。
  • Acute pancreatitis, incidence rate around 1~7%。
  • Infection, such as cholangitis (<1%), cholecystitis (0.2~0.5%), aspiration pneumonia.
  • Unpredictable complications, such as arrhythmia, acute respiratory failure, shock.


Estimated Cost

Prices are subject to change without prior notice, need to pay in accordance with the actual medical expenses.